Bookmark
Forward
Don't worry about the drug industry's profits when considering a waiver on covid-19 intellectual property rights.
Luke Hawksbee, Martin McKee, Lawrence King
BMJ (Clinical research ed.) 2022 Jan 31
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Luke Hawksbee, Martin McKee, Lawrence King.
Don't worry about the drug industry's profits when considering a waiver on covid-19 intellectual property rights.
BMJ (Clinical research ed.).
2022 Jan 31;376:e067367
Mesh Tags
COVID-19
COVID-19 Vaccines
Drug Industry
Humans
Intellectual Property
Public Policy
SARS-CoV-2
Substances
COVID-19 Vaccines
PMID: 35101900
View Full Text